Hypothalamic leptin and ghrelin signaling as targets for improvement in metabolic control

Current Pharmaceutical Design

Volumn 21, Issue 25, 2015, Pages 3596-3605

  Frago, Laura M ^a   Chowen, Julie A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Ghrelin; Hypothalamus; Leptin; Metabolism; Obesity

Indexed keywords

GHRELIN; LEPTIN; LEPTIN RECEPTOR;

ARTICLE; ASTROCYTE; CALORIC INTAKE; ENERGY BALANCE; EXERCISE; FOOD INTAKE; GLUCONEOGENESIS; HORMONAL THERAPY; HORMONE TRANSPORT; HUMAN; HUNGER; HYPOTHALAMUS; IMMUNOSUPPRESSIVE TREATMENT; METABOLIC REGULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TANYCYTE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DEVELOPMENT; DRUG EFFECTS; FEEDING BEHAVIOR; GENETICS; METABOLISM;

ANIMALS; APPETITE REGULATION; DRUG DISCOVERY; EXERCISE; FEEDING BEHAVIOR; GHRELIN; HUMANS; HYPOTHALAMUS; LEPTIN; OBESITY; SIGNAL TRANSDUCTION;

EID: 84940902953     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150710145428     Document Type: Article

References (128)

1. Zhang Y, Proenca R, Maffel M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402(6762): 656-60.
3. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480-4.
4. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-61.
5. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004; 304: 108-10.
6. Steculorum SM, Collden G, Coupe B, et al. Neonatal ghrelin programs development of hypothalamic feeding circuits. J Clin Invest 2015; 125(2): 846-58.
7. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998; 101Suppl 2: S518-25.
8. Vucenik I, Stains JP. Obesity and cancer risk: evidence, mechanisms, and recommendations. Annl New York Acad Sci 2012; 1271: 37-43.
9. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000: 404: 661-71.
10. Van den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci 2004; 7: 493-4.
11. Ollmann MM, Wilson BD, Yang Y-K, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-8.
12. Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 2007; 92: 263-71.
13. Wittmann G, Hrabovszky E, Lechan RM. Distinct glutamatergic and GABAergic subsets of hypothalamic pro-opiomelanocortin neurons revealed by in situ hybridization in male rats and mice. J Comparative Neurol 2013; 521: 3287-302.
14. WisseBE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-800.
15. Wilding JP, Gilbey SG, Bailey CJ, et al. Increased neuropeptide Y mRNA and decreased neurotensin mRNA in the hypothalamus of the ob/ob mouse. Endocrinology 1993; 132: 1939-44.
16. Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997; 138: 5063-66.
17. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature, 2006; 443: 289-95.
18. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-70.
19. Farooqi IS, O'Rahilly S. Recent advances in the genetics of severe childhood obesity. Arch Dis Child 2000; 83(1): 31-34.
20. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-25.
21. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ. Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature 1997; 387: 903-8.
22. Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007, 356: 237-47.
23. Mackowski M, Szymoniak K, Szydlowski M, et al. Missense mutations in exon 4 of the porcine LEPR gene encoding extracellular domain and their association with fatness traits. Animal Genetics 2005; 36: 135-7.
24. Farooqi IS, O'Rahilly S. Genetics of obesity in humans. Endocrine Rev 2006; 27: 710-8.
25. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-95.
26. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile- onset obesity. J Clin Endocrinol Metab 2005; 90: 219-24.
27. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and earlyonset obesity due to a novel homozygous missense mutation in prohormoneconvertase 1/3. J Clin Endocrinol Metabol 2007; 92: 3369- 73.
28. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531-5.
29. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76.
30. Morton GJ, Niswender KD, Rhodes CJ, Myers MG Jr, Blevins JE, Baskin DG. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa k/fa k) rats. Endocrinology 2003; 144: 2016-24.
31. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341(12): 879-84.
32. Paz-Filho G, Delibasi T, Erol HK, Wong ML, Licinio J. Congenital leptin deficiency and thyroid function. Thyroid Res 2009; 2(1): 11.
33. Lee GH, Proenca, R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-5.
34. Fei H, Okano HJ, Li C, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997; 94: 7001-05.
35. Barr VA, Lane K, Taylor SI. Subcellular localization and internalization of the four human leptin receptor isoforms. J Biol Chem 1999; 274: 21416-24.
36. Devos R, Richards JG, Campfield LA, et al. OB protein binds specifically to the choroid plexus of mice and rats. Proc Nat Acad Sci USA 1996; 93: 5668-73.
37. Hileman SM, Pierroz DD, Masuzaki H, et al. Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 2002; 143: 775-83.
38. Bjørbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305-31.
39. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263- 71.
40. Glaum SR, Hara M, Bindokas VP, et al. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 1996; 50: 230-5.
41. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999; 22: 221-32.
42. Mercer JG, Hoggard N, Williams LM, Lawrence C B, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS letters 1996; 387: 113- 6.
43. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101.
44. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93(13): 6231-35.
45. Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1(4): 619-25.
46. Kaszubska W, Falls HD, Schaefer VG, et al. Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line. Mol Cell Endocrinol 2002; 195 (1-2): 109-18.
47. Watowich SS, Wu H, Socolovsky M, Klingmuller U, Constantinescu SN, Lodish HF. Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol 1996; 12: 91-128.
48. Szanto I, Kahn CR. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA 2000; 97(5): 2355-60.
49. Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW. Leptin regulates insulin sensitivity via phosphatidylinositol- 3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metabol 2005; 2(6): 411-20.
50. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: The role of leptin in human physiology: Emerging clinical applications. Annl Int Med 2010; 152: 93-100.
51. Pinto S, Roseberry AG, Liu H, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004; 304: 110-15.
52. Garcia-Caceres C, Fuente-Martin E, Burgos-Ramos E, et al. Differential acute and chronic effects of leptin on hypothalamic astrocyte morphology and synaptic protein levels. Endocrinology 2011; 152: 1809-18.
53. Hsuchou H1, He Y, Kastin AJ, et al. Obesity induces functional astrocyticleptin receptors in hypothalamus. Brain 2009; 132: 889- 902.
54. Fuente-Martín E, García-Cáceres C, Granado M, et al. Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J Clin Invest 2012; 11: 3900-13.
55. Tang CH, Lu DY, Yang RS, et al. Leptin-Induced IL-6 Production Is Mediated by Leptin Receptor, Insulin Receptor Substrate-1, phosphatidylinositol 3-Kinase, Akt, NF-κB, and p300 Pathway in Microglia. J Immunol 2007; 179: 1292-302.
56. Ioffe E, Moon B, Connolly E, Friedman JM. Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci USA 1998; 95(20): 11852-7.
57. Myers MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and Leptin Resistance: Distinguishing Cause from Effect. Trends in endocrinology and metabolism: TEM2010; 21(11): 643-51.
58. Roujeau C, Jockers R, Dam J. New Pharmacological Perspectives for the Leptin Receptor in the Treatment of Obesity. Front Endocrinol 2014; 5: 167.
59. Banks WA. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des 2001; 7: 125-33.
60. Tu H, Kastin AJ, Hsuchou H, Pan W. Soluble receptor inhibits leptin transport. J Cell Physiol 2008; 214: 301-5.
61. Shimizu H, Shimomura K, Negishi M, et al. Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition 2002; 18 309-12.
62. Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring) 2009; 18: 221-9.
63. Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008; 70: 537-56.
64. Mori H, Hanada R, Hanada T, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 2004; 10: 739-43.
65. Carpenter LR, Farruggella TJ, Symes A, Karow ML, Yancopoulos GD, Stahl N. Enhancing leptin response by preventing SH2- containing phosphatase 2 interaction with Ob receptor. Proc Natl Acad Sci USA 1998; 95: 6061-6.
66. Tsou RC, Rak KS, Zimmer DJ, Bence KK. Improved metabolic phenotype of hypothalamic PTP1B-deficiency is dependent upon the leptin receptor. Mol Metab 2014; 3(3): 301-12.
67. Boden G, Duan X, Homko C, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin- resistant individuals. Diabetes 2008; 57(9): 2438-44.
68. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009; 9: 35-51.
69. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal- fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348(9021): 159-61.
70. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2: 589-93.
71. Faouzi M, Leshan R, Björnholm M, Hennessey T, Jones J, Münzberg H. Differential accessibility of circulating leptin to individual hypothalamic sites. Endocrinology 2007; 148: 5414-23
72. Langlet F, Levin BE, Luquet S, et al. Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab 2013; 17: 607-17.
73. Balland E, Dam J, Langlet F, et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell metabolism 2014; 19: 293-301.
74. Mullier A, Bouret SG, Prevot V, Dehouck B. Differential distribution of tight junction proteins suggests a role for tanycytes in bloodhypothalamus barrier regulation in the adult mouse brain. J Comp Neurol 2010; 518: 943-62.
75. Li Y-C, Bai W-Z, Sakai K, Hashikawa T. Fluorescence and electron microscopic localization of F-actin in the ependymocytes. J Histochem Cytochem 2009; 57(8): 741-51.
76. Briggs DI, Enriori PJ, Lemus MB, Cowley MA, Andrews ZB. Dietinduced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010; 151: 4745-55.
77. McNay DE, Briançon N, Kokoeva MV, Maratos-Flier E, Flier JS. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J Clin Invest 2012; 122: 142-52.
78. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873-904.
79. Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 2007; 7: 643-7.
80. Schulz C, Paulus K, Lehnert H. Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 2004; 145: 2696-2701.
81. Freemark M. Pharmacotherapy of childhood obesity: An evidencebased, conceptual approach. Diabetes Care 2007; 30: 395.
82. Roth J D, Trevaskis JL, Turek VF, Parkes DG. "Weighing in" on synergy: Preclinical research on neurohormonal anti-obesity combinations. Brain research 2010; 1350: 86-94.
83. Couce ME, Green D, Brunetto A, Lloyd RV, Burguera B. Limited brain access for leptin in obesity. Pituitary 2001; 4: 101-10.
84. Muzzin P, Eisensmith RC, Copeland KC, Woo SL. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci 1996; 93(25): 14804-8.
85. O'Neill SM, Hinkle C, Chen SJ, et al. Targeting adipose tissue via systemic gene therapy. Gene Ther 2014; 21(7): 653-61.
86. Tutone M, Lauria A, Maria Almerico A. Leptin and the OBreceptor as anti-obesity target: recent in silico advances in the comprehension of the protein-protein interaction and rational drug design of anti-obesity lead compounds. Curr Pharm Des 2014; 20: 136-45.
87. Samson WK, Murphy TC, Robison D, Vargas T, Tau E, Chang JK. A 35 amino acid fragment of leptin inhibits feeding in the rat. Endocrinology 1996; 137: 5182-5.
88. Kraynov V, Putnam AH, Knudsen N, et al. Modified Leptin Polypeptides and Their Uses. European patent Office: WO/2009/100255 2009 Aug 8.
89. Müller TD, Sullivan LM, Habegger K, et al. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21. J Pept Sci 2012; 18: 383-93.
90. Grasso P, Lee DW, Leinungm MC. Leptin-related peptides. US Patent: 7208572B2 2007.
91. Grasso P, Rozhavskaya-Arena M, Leinung MC, Lee DW. [D-LEU- 4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice. Regul Pept 2001; 101(1-3): 123-9.
92. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-13.
93. McKibben B. Ghrelin: The hunger hormone. Adv Biochem 2007: 1-12
94. Sangiao-Alvarellos S, CordidoF. Effect of ghrelin on glucoseinsulin homeostasis: therapeutic implications. Int J Peptides 2010; Article ID 234709, 25 pages.
95. Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW. High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol Endocrinol 2003; 17: 2201-10.
96. Ferrini F, Salio C, Lossi L, Merighi A. Ghrelin in central neurons. Curr Neuropharmacol 2009; 7(1): 37-49.
97. Perello M, Spinedi E. Aspectos neuroendocrinos de la obesidad. Medicina (Buenos Aires) 2004; 64(3): 257-64.
98. Kola B, Korbonits M. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation. J Endocrinol 2009; 202(2): 191-8.
99. López M, Lage R, Saha AK, et al. Hypothalamic fattyacid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008; 7(5): 389-99.
100. Wang L, Saint-Pierre DH, Taché Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 2002; 325(1): 47-51.
101. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123(4): 1120-8.
102. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50(8): 1714-9.
103. Kojima M, Kangawa K. Ghrelin: Structure and function. Physiol Rev 2005; 85: 495-522.
104. Aller EEJG, Abete I, Astrup A, Martinez JA, van Baak MA. Starches, sugars and obesity. Nutrients 2011; 3(3): 341-69.
105. Foster-Schubert KE, Cummings DE: Emerging therapeutic strategies for obesity. Endocr Rev 2006; 27: 779.
106. Lee HM, Wang G, Englander EW, Kojima M, Greeley JrGH. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002; 143(1): 185-90.
107. Pinto S, Roseberry AG, Liu H, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004; 304(5667): 110-5.
108. García-Cáceres C, Fuente-Martín E, Díaz F, et al. The opposing effects of ghrelin on hypothalamic and systemic inflammatory processes are modulated by its acylation status and food intake in male rats. Endocrinology 2014; 155(8): 2868-80.
109. Baquedano E, Chowen JA, Argente J, Frago LM. Differential effects of GH and GH-releasing peptide-6 on astrocytes. J Endocrinol 2013; 218(3): 263-74.
110. Horvath TL, Castañeda T, Tang-Christensen M, Pagotto U, Tschop MH. Ghrelin as a potential anti-obesity Target. Curr Pharm Des 2003; 9: 1383-95.
111. Asakawa A, Inui A, Kaga T, et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003; 52(7): 947-52.
112. Delporte C. Recent advances in potential clinical application of ghrelin in obesity. J Obesity 2012; vol 2012, Article ID 535624, 8 pages.
113. Solomou S, Korbonits M. The role of ghrelin in weight-regulation disorders: implications in clinical practice. Hormones 2014; 13: 458-75.
114. Chen C, Asakawa A, Fujimiya M, Lee S, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009; 61(4): 430-81.
115. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacological Sci 2004; 25(3): 113-7.
116. Zorrilla EP, Iwasaki S, Moss JA, et al. Vaccination against weight gain. Proc Natl Acad Sci USA 2006; 103: 13226-31.
117. Patterson M, Bloom SR, Gardiner JV. Ghrelin and appetite control in humans-Potential application in the treatment of obesity. Peptides 2011; 32: 2290-4.
118. Chaput JP, Klingenberg L, Rosenkilde M, Gilbert JA, Tremblay A, Sjodin A. Physical activity plays an important role in body weight regulation. J Obesity 2011; 2011, Article ID 360257.
119. Wang J, Chen C, Wang RY. Influence of short-and long-term treadmill exercises on levels of ghrelin, obestatin and NPY in plasma and brain extraction of obese rats. Endocrine 2008; 33(1): 77-83.
120. Burns SF, Broom DR, Miyashita M, Mundy C, Stensel DJ. A single session of treadmill running has no effect on plasma total ghrelin concentrations. J Sports Sci Med 2007; 25: 635-42.
121. Vatansever-Ozen S, Tiryaki-Sonmez G, Yuktasir B, Yalcin HB, Bugdayci G, Willems M. Effects of exercise on leptine and acylated ghrelina hormones in trained males. JE Ponline 2010; 12(2): 20-30.
122. Broom DR, Stensel DJ, Bishop NC, Burns SF, Miyashita M. Exercise- induced suppression of acylated ghrelin in humans. J Appl Physiol 2007; 102: 2165-71.
123. Kim HJ, Lee S, Kim TW, et al. Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clin Endocrinol 2008; 68: 416-422.
124. Mirzaei B, Irandoust K, Rahmani-Nia F, Mohebbi H, Hassan-Nia S. Unacylated Ghrelin levels increase after aerobic exercise program in obese women. Braz J Biomotricity 2009; 3: 11-20.
125. Erdmann J, Tahbaz R, Lippl F, Wagenpfeil S, Schusdziarra V. Plasma ghrelin levels during exercise - Effects of intensity and duration. Regulatory Peptides 2007; 143: 127-35.
126. Olive J, Miller G. Differential effects of maximal- and moderateintensity runs on plasma leptin in healthy trained subjects. Nutrition 2001; 17(5): 365-9.
127. Flores MB, Fernandes MFA, Ropelle ER, et al. Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 2006; 55(9): 2554-61.
128. Ropelle ER, Flores MB, Cintra DE, et al. IL-6 and IL-10 antiinflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 2010; 24: 8(8).